Onconetix, Inc. (ONCO)
NASDAQ: ONCO · Real-Time Price · USD
1.410
-0.010 (-0.70%)
At close: Feb 2, 2026, 4:00 PM EST
1.420
+0.010 (0.71%)
After-hours: Feb 2, 2026, 6:30 PM EST

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2023
Period Ending
Dec '23
Vaccine Discovery and Development
58.47K

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2023
Period Ending
Dec '23
Switzerland
58.47K